|
interprofessional education |
62 |
|
social interaction anxiety |
40 |
|
humans |
29 |
|
partnership model |
28 |
|
male |
21 |
|
animals |
20 |
|
bronchiectasis |
16 |
|
construct validation |
16 |
|
female |
16 |
|
medical sciences |
16 |
|
cluster analysis |
15 |
|
medical education |
15 |
|
middle aged |
12 |
|
achievement emotions |
11 |
|
adult |
11 |
|
healthcare students |
11 |
|
interprofessional collaboration |
11 |
|
oxidative stress |
11 |
|
person-centred analysis |
11 |
|
birds |
10 |
|
chemicals and cas registry numbers |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza, human - enzymology - virology |
10 |
|
pseudomonas aeruginosa |
10 |
|
validation |
10 |
|
inflammation |
9 |
|
mice |
9 |
|
nitric oxide |
9 |
|
self-determination theory |
9 |
|
aged |
8 |
|
carbon tetrachloride |
8 |
|
enzyme-linked immunosorbent assay |
8 |
|
rats |
8 |
|
up-regulation |
8 |
|
anti-inflammatory agents - pharmacology |
7 |
|
bacterial adherence |
7 |
|
basic psychological needs |
7 |
|
case-control studies |
7 |
|
cells, cultured |
7 |
|
cilia |
7 |
|
drug modulation |
7 |
|
epithelial cells |
7 |
|
forced expiratory volume - physiology |
7 |
|
mice, inbred c57bl |
7 |
|
microscopy, electron, scanning |
7 |
|
person-centered analysis |
7 |
|
reverse transcriptase polymerase chain reaction |
7 |
|
student engagement |
7 |
|
transmission electronic microscopy |
7 |
|
vital capacity |
7 |
|
adhesion molecules |
6 |
|
anatomy |
6 |
|
bronchiectasis - metabolism |
6 |
|
cadaver study |
6 |
|
cardiovascular disease |
6 |
|
ciliary central microtubular orientation |
6 |
|
construct validity |
6 |
|
disease models, animal |
6 |
|
endocrinology |
6 |
|
fibrosis |
6 |
|
health professions students |
6 |
|
intercalation enrichment year |
6 |
|
interleukin-6 |
6 |
|
interleukin-6 - biosynthesis |
6 |
|
learning experience |
6 |
|
liver injury |
6 |
|
lycium barbarum polysaccharides |
6 |
|
mixed-method study |
6 |
|
neurotransmission |
6 |
|
percutaneous nailing |
6 |
|
prospective studies |
6 |
|
proximal humerus fracture |
6 |
|
rats, sprague-dawley |
6 |
|
rotator cuff injury |
6 |
|
scale application |
6 |
|
undergraduate medicine curriculum |
6 |
|
administration, inhalation |
5 |
|
alanine transaminase - blood |
5 |
|
androstadienes - administration & dosage |
5 |
|
anti-inflammatory agents - isolation & purification - pharmacology |
5 |
|
antioxidants - isolation & purification - pharmacology |
5 |
|
asia |
5 |
|
bronchiectasis - drug therapy |
5 |
|
conceptualisation |
5 |
|
confirmatory factor analysis |
5 |
|
culture |
5 |
|
cyclooxygenase |
5 |
|
cytochrome p-450 cyp2e1 - antagonists & inhibitors - metabolism |
5 |
|
cytokines - genetics - metabolism |
5 |
|
cytoprotection |
5 |
|
distress |
5 |
|
drug-induced liver injury - etiology - genetics - metabolism - pathology - prevention & control |
5 |
|
drugs, chinese herbal - isolation & purification - pharmacology |
5 |
|
educators |
5 |
|
endothelium-dependent contractions |
5 |
|
engagement |
5 |
|
enzyme inhibitors - pharmacology |
5 |
|
epwbi |
5 |
|
gene expression regulation, enzymologic - drug effects |
5 |
|
immunohistochemistry |
5 |
|
inflammation mediators - metabolism |
5 |
|
inhaled corticosteroid therapy |
5 |
|
interprofessional attitudes |
5 |
|
interventions |
5 |
|
lipid peroxidation - drug effects |
5 |
|
liver |
5 |
|
liver - drug effects - metabolism - pathology |
5 |
|
lycium - chemistry |
5 |
|
mediation |
5 |
|
medical educators |
5 |
|
motivation |
5 |
|
necrosis |
5 |
|
nf-kappa b - metabolism |
5 |
|
nitric oxide - metabolism |
5 |
|
non-alcoholic fatty liver disease |
5 |
|
nuclear factor kappa-b |
5 |
|
online interprofessional education |
5 |
|
oxidative stress - drug effects |
5 |
|
pathogenesis |
5 |
|
peer relatedness |
5 |
|
physician educators |
5 |
|
physician well-being index-expanded |
5 |
|
plants, medicinal |
5 |
|
ppct model |
5 |
|
probability |
5 |
|
psychometrics |
5 |
|
resilience |
5 |
|
rna, messenger - analysis |
5 |
|
s-allylmercaptocysteine |
5 |
|
socio-ecological |
5 |
|
statistics, nonparametric |
5 |
|
teachers |
5 |
|
well-being |
5 |
|
aged, 80 and over |
4 |
|
anti-inflammatory agents, non-steroidal - pharmacology |
4 |
|
aorta |
4 |
|
aorta - physiology |
4 |
|
apoptosis |
4 |
|
bacterial adhesion - drug effects |
4 |
|
bacterial morphology |
4 |
|
biological availability |
4 |
|
brain inflammation |
4 |
|
bronchi - immunology |
4 |
|
bronchial epithelial cells |
4 |
|
bronchiectasis - blood - etiology |
4 |
|
bronchiectasis - immunology |
4 |
|
cell hypoxia |
4 |
|
cerebellar ataxia |
4 |
|
china |
4 |
|
chronic periodontitis |
4 |
|
chronic periodontitis - metabolism - pathology |
4 |
|
cilia - physiology - ultrastructure |
4 |
|
co-regulation |
4 |
|
cognitive congruence |
4 |
|
collagen - physiology |
4 |
|
collective efficacy |
4 |
|
community of inquiry |
4 |
|
culture media, conditioned |
4 |
|
cyclooxygenase 1 - physiology |
4 |
|
cyclooxygenase 2 - physiology |
4 |
|
cyclooxygenase 2 inhibitors - pharmacology |
4 |
|
dose-response relationship, drug |
4 |
|
educational measurement |
4 |
|
egcg |
4 |
|
endothelial cells - metabolism - pathology |
4 |
|
endothelin-1 - metabolism |
4 |
|
endothelium, vascular - physiology |
4 |
|
endothelium-derived contracting factors |
4 |
|
epithelial cells - drug effects - immunology |
4 |
|
epithelial cells - metabolism - pathology |
4 |
|
erythromycin |
4 |
|
erythromycin - pharmacology |
4 |
|
hericium erinaceus |
4 |
|
hypoxia-inducible factor 1-α subunit |
4 |
|
immunosuppressive agents - pharmacology |
4 |
|
incoordination |
4 |
|
intercellular adhesion molecule-1 - analysis |
4 |
|
intercellular cell adhesion molecule |
4 |
|
intermittent hypoxia |
4 |
|
intestinal fat absorption |
4 |
|
lipid homeostasis |
4 |
|
lipid peroxidation |
4 |
|
melatonin |
4 |
|
metabolic syndrome |
4 |
|
microscopy, electron |
4 |
|
necroinflammation |
4 |
|
neuroprotective agents |
4 |
|
neutrophils |
4 |
|
nuclear factor κb |
4 |
|
path analysis |
4 |
|
peer teaching |
4 |
|
phospholipid-binding protein |
4 |
|
pseudomonas aeruginosa - drug effects - physiology |
4 |
|
reactive oxygen species |
4 |
|
recycling endosome |
4 |
|
self-regulation |
4 |
|
sensitivity and specificity |
4 |
|
serum |
4 |
|
sleep apnea |
4 |
|
social congruence |
4 |
|
student facilitator |
4 |
|
subminimal inhibitory concentration |
4 |
|
team cohesiveness |
4 |
|
team collaboration |
4 |
|
time factors |
4 |
|
transforming growth factor beta - metabolism |
4 |
|
transforming growth factor beta1 |
4 |
|
transforming growth factor-β1 |
4 |
|
tumor necrosis factor-alpha |
4 |
|
tumor necrosis factor-alpha - analysis - pharmacology |
4 |
|
tumor necrosis factor-α |
4 |
|
vascular endothelial growth factor a |
4 |
|
vasoconstriction |
4 |
|
3d printed models |
3 |
|
3d printing |
3 |
|
3d spheroid based drug sensitivity assay |
3 |
|
adrenomedullin - genetics - metabolism |
3 |
|
aging - genetics - metabolism |
3 |
|
alcoholic liver disease |
3 |
|
alzheimer’s disease |
3 |
|
amino acids - pharmacology |
3 |
|
anatomy and medical education |
3 |
|
animal cell |
3 |
|
anoxia - genetics - metabolism |
3 |
|
anoxia - genetics - metabolism - pathology |
3 |
|
anoxia - metabolism |
3 |
|
anoxia - metabolism - pathology - prevention & control |
3 |
|
anti-oxidant |
3 |
|
antioxidant enzymes |
3 |
|
aorta - metabolism |
3 |
|
aquaporin 3 |
3 |
|
aquaporins |
3 |
|
aquaporins - metabolism |
3 |
|
autophagy |
3 |
|
autophagy (cellular) |
3 |
|
bacterial adhesion - drug effects - physiology |
3 |
|
basement membrane |
3 |
|
basement membrane - drug effects - physiopathology - ultrastructure |
3 |
|
bioassay |
3 |
|
bone morphogenetic protein 4 - antagonists & inhibitors - metabolism |
3 |
|
bone morphogenetic protein receptors, type i - metabolism |
3 |
|
bone morphogenic protein 4 |
3 |
|
bronchi - metabolism |
3 |
|
bronchial biopsy |
3 |
|
bronchiectasis - blood - physiopathology |
3 |
|
bronchiectasis - metabolism - physiopathology |
3 |
|
bronchiectasis - pathology |
3 |
|
bronchiectasis - pathology - radiography |
3 |
|
bronchiectasis - physiopathology |
3 |
|
calcitonin receptor-like protein |
3 |
|
carbohydrates - pharmacology |
3 |
|
carcinogenesis |
3 |
|
carotid body |
3 |
|
carotid body - metabolism |
3 |
|
carrier proteins - metabolism - pharmacology |
3 |
|
chronic aerobic exercise |
3 |
|
chronic disease |
3 |
|
chronic hypoxia |
3 |
|
cilia - ultrastructure |
3 |
|
collaboration outcomes |
3 |
|
collagen |
3 |
|
collagen type iv - drug effects - physiology - ultrastructure |
3 |
|
colony count, microbial |
3 |
|
cx3cr1 |
3 |
|
cyclooxygenase 2 - genetics - metabolism |
3 |
|
cyclooxygenase-2 |
3 |
|
cystic fibrosis - physiopathology |
3 |
|
cysts |
3 |
|
cytokines |
3 |
|
down-regulation |
3 |
|
e-selectin - blood |
3 |
|
electrophoresis |
3 |
|
embryonic stem cells |
3 |
|
endothelial dysfunction |
3 |
|
endothelium, vascular - metabolism |
3 |
|
environmental factors |
3 |
|
forced expiratory volume |
3 |
|
gene expression regulation, developmental |
3 |
|
hippocampus - drug effects - metabolism - pathology |
3 |
|
human anatomy |
3 |
|
hypertension |
3 |
|
hypertension, renal - metabolism |
3 |
|
hypoxia-inducible factor 1 - biosynthesis - genetics |
3 |
|
induced pluripotent stem cells |
3 |
|
inflammation mediators - therapeutic use |
3 |
|
intercellular adhesion molecule-1 - blood |
3 |
|
ions - pharmacology |
3 |
|
ischemia |
3 |
|
kupffer cell |
3 |
|
lectins - pharmacology |
3 |
|
liver fibrosis |
3 |
|
lung - metabolism - pathology |
3 |
|
lung injury |
3 |
|
mad2 |
3 |
|
map kinase signaling system - physiology |
3 |
|
melatonin - administration & dosage - therapeutic use |
3 |
|
mesenchymal stem cells |
3 |
|
microglia |
3 |
|
microscopy, electron, transmission |
3 |
|
microtubular defects |
3 |
|
microtubules |
3 |
|
microtubules - ultrastructure |
3 |
|
minocycline |
3 |
|
mitosis |
3 |
|
mixed function oxygenases - genetics |
3 |
|
mucus |
3 |
|
multienzyme complexes - genetics |
3 |
|
nafld |
3 |
|
nasal mucosa - cytology - ultrastructure |
3 |
|
necrotizing enterocolitis |
3 |
|
neural stem cells |
3 |
|
neurodegenerative disease |
3 |
|
neurogenesis |
3 |
|
neuroprotective agents - administration & dosage - therapeutic use |
3 |
|
oxidative stress - physiology |
3 |
|
p38 mitogen-activated protein kinases - metabolism |
3 |
|
pancreatic elastase - analysis |
3 |
|
personal factors |
3 |
|
photoreceptor degeneration |
3 |
|
polyphenols |
3 |
|
polyribosomes - metabolism |
3 |
|
proinflammatory cytokines |
3 |
|
protein precursors - genetics |
3 |
|
pseudomonas aeruginosa - drug effects - physiology - ultrastructure |
3 |
|
radioimmunoassay |
3 |
|
rats, inbred shr |
3 |
|
rats, inbred wky |
3 |
|
rd10 mice |
3 |
|
reactive oxygen species - metabolism |
3 |
|
receptors, calcitonin - genetics |
3 |
|
renal artery - physiology |
3 |
|
reperfusion injury |
3 |
|
rna, messenger - genetics |
3 |
|
rna, messenger - genetics - metabolism |
3 |
|
son |
3 |
|
spirometry |
3 |
|
splicing factor |
3 |
|
sputum - microbiology |
3 |
|
stem cell therapy |
3 |
|
stem cell transplantation |
3 |
|
stem cells |
3 |
|
toll-like receptor |
3 |
|
tomography, x-ray computed |
3 |
|
transcription factors - genetics - metabolism |
3 |
|
undergraduate medical education |
3 |
|
up-regulation - drug effects - physiology |
3 |
|
vascular cell adhesion molecule-1 - blood |
3 |
|
vital capacity - physiology |
3 |
|
xenopus proteins |
3 |
|
5-lipoxygenase |
2 |
|
acidosis, respiratory - drug therapy - metabolism |
2 |
|
actins - metabolism |
2 |
|
active learning |
2 |
|
acute liver injury |
2 |
|
adaptation, physiological |
2 |
|
adaptation, physiological - physiology |
2 |
|
adolescent |
2 |
|
aerobic exercise |
2 |
|
aging |
2 |
|
aging - metabolism |
2 |
|
aging - pathology - physiology |
2 |
|
alanine transaminase - metabolism |
2 |
|
alcoholic fatty liver disease |
2 |
|
alternative medicine |
2 |
|
ampk |
2 |
|
anatomy - education |
2 |
|
anatomy learning challenges |
2 |
|
androstadienes - pharmacology |
2 |
|
anoxia - etiology - physiopathology |
2 |
|
anoxia - genetics - physiopathology |
2 |
|
anoxia - metabolism - pathology |
2 |
|
anti-inflammation |
2 |
|
anti-inflammatory agents - therapeutic use |
2 |
|
anti-inflammatory agents, non-steroidal |
2 |
|
antioxidants |
2 |
|
arginine - pharmacology |
2 |
|
autophagosome |
2 |
|
base sequence |
2 |
|
basic helix-loop-helix transcription factors |
2 |
|
basic helix-loop-helix transcription factors - genetics - metabolism |
2 |
|
bequest program |
2 |
|
biochemistry |
2 |
|
blood cell count |
2 |
|
blood pressure - drug effects |
2 |
|
blotting, western - methods |
2 |
|
body constitution |
2 |
|
body donation |
2 |
|
body mass index |
2 |
|
body parts |
2 |
|
body surface area |
2 |
|
body temperature - drug effects |
2 |
|
body weight - drug effects |
2 |
|
brain - drug effects |
2 |
|
breath tests - instrumentation |
2 |
|
bronchi - cytology - drug effects - metabolism |
2 |
|
bronchiectasis - complications - metabolism - microbiology |
2 |
|
budesonide - pharmacology |
2 |
|
cadaver |
2 |
|
cadaveric study |
2 |
|
calcium - metabolism |
2 |
|
carbon tetrachloride (ccl 4) |
2 |
|
cardiotonic agents |
2 |
|
cardiovascular |
2 |
|
cardiovascular diseases - prevention & control |
2 |
|
carotid arteries - metabolism |
2 |
|
carotid body - cytology - drug effects - metabolism |
2 |
|
carotid body - drug effects - metabolism |
2 |
|
carotid body - drug effects - physiopathology |
2 |
|
carotid body - metabolism - pathology |
2 |
|
carotid body - physiopathology |
2 |
|
carotid body, hypoxia, protein expression |
2 |
|
carotid chemoreceptor |
2 |
|
carpal tunnel syndrome |
2 |
|
catalase |
2 |
|
catechin - analogs & derivatives - therapeutic use |
2 |
|
cellular injury |
2 |
|
chemoreceptor |
2 |
|
chemoreceptor cells - drug effects |
2 |
|
chemoreceptor cells - drug effects - physiopathology |
2 |
|
chemoreceptor cells - metabolism |
2 |
|
chemoreceptor cells - physiology |
2 |
|
chemoreceptors, carotid body |
2 |
|
chi-square distribution |
2 |
|
child |
2 |
|
chinese culture |
2 |
|
chronic intermittent hypoxia |
2 |
|
chronic liver injury |
2 |
|
circadian |
2 |
|
circadian rhythm - physiology |
2 |
|
collagen type i - metabolism |
2 |
|
communication barriers |
2 |
|
computer-assisted instruction |
2 |
|
computers |
2 |
|
control of breathing, hypoxia, carotid body |
2 |
|
corn oil |
2 |
|
curriculum |
2 |
|
curriculum design |
2 |
|
cyclooxygenase 2 inhibitors - metabolism |
2 |
|
dexamethasone |
2 |
|
dexamethasone - pharmacology |
2 |
|
disease progression |
2 |
|
dna, complementary - genetics |
2 |
|
drug evaluation, preclinical |
2 |
|
drug toxicity |
2 |
|
drug-induced liver injury - drug therapy - metabolism |
2 |
|
education measurement |
2 |
|
education, medical undergraduate, methods |
2 |
|
education, medical, undergraduate |
2 |
|
education, medical, undergraduate - methods |
2 |
|
electrodes |
2 |
|
electrophoretic mobility shift assay - methods |
2 |
|
electrophysiology |
2 |
|
electrophysiology - methods |
2 |
|
endoscopic carpal tunnel release |
2 |
|
endothelin |
2 |
|
endothelin receptor |
2 |
|
endothelin-1 |
2 |
|
endothelin-1 - genetics - metabolism |
2 |
|
endothelin-1 - metabolism - pharmacology |
2 |
|
endothelin-1 - metabolism - physiology |
2 |
|
epigallocatechin gallate (egcg) |
2 |
|
epigallocatechin-3-gallate (egcg) |
2 |
|
epithelial cells - drug effects - metabolism |
2 |
|
erythropoietin |
2 |
|
erythropoietin - metabolism |
2 |
|
erythropoietin - metabolism - physiology |
2 |
|
et-1 |
2 |
|
eta receptors |
2 |
|
exhaled nitric oxide |
2 |
|
flavonoids - pharmacology |
2 |
|
fluticasone |
2 |
|
free radical scavengers - metabolism |
2 |
|
free radicals |
2 |
|
fura-2 - metabolism |
2 |
|
ganoderma lucidum |
2 |
|
garlic-derived monomers |
2 |
|
gender |
2 |
|
gene expression |
2 |
|
gene expression regulation |
2 |
|
glomus cell |
2 |
|
glucocorticoids - pharmacology |
2 |
|
glutathone peroxidase |
2 |
|
green tea |
2 |
|
gross anatomy education |
2 |
|
hcc |
2 |
|
heart rate - drug effects |
2 |
|
hematology |
2 |
|
herbal treatment |
2 |
|
hif |
2 |
|
histology |
2 |
|
hong kong |
2 |
|
human |
2 |
|
hypercapnia |
2 |
|
hypercapnia - drug therapy - metabolism |
2 |
|
hypercapnia - metabolism |
2 |
|
hypoxia |
2 |
|
hypoxia, carotid body, hif-1α, vegf |
2 |
|
hypoxia-inducible factor |
2 |
|
hypoxia-inducible factor 1 - genetics - physiology |
2 |
|
hypoxia-inducible factor 1, alpha subunit |
2 |
|
hypoxia-inducible factor 1, alpha subunit - genetics - metabolism |
2 |
|
hypoxia-inducible factor 1, alpha subunit - metabolism |
2 |
|
immediate receptor |
2 |
|
in situ hybridization |
2 |
|
inflammasome |
2 |
|
injections, intravenous |
2 |
|
innovative technology |
2 |
|
interleukin |
2 |
|
interleukin-1 - analysis |
2 |
|
interleukin-1 - pharmacology |
2 |
|
interleukin-8 |
2 |
|
interleukin-8 - analysis |
2 |
|
interleukin-8 - secretion |
2 |
|
internet of things |
2 |
|
interprofessional identity |
2 |
|
isothiuronium - analogs & derivatives - pharmacology |
2 |
|
iype i cells |
2 |
|
knowledge acquisition |
2 |
|
l-arginine |
2 |
|
l-name |
2 |
|
language |
2 |
|
lard |
2 |
|
lbp |
2 |
|
learning |
2 |
|
leukocytes |
2 |
|
liver - chemistry - enzymology |
2 |
|
liver - physiopathology |
2 |
|
liver cirrhosis - drug therapy - metabolism |
2 |
|
liver cirrhosis - enzymology |
2 |
|
liver inflammation |
2 |
|
lrp6 |
2 |
|
luminescent measurements |
2 |
|
lysosomal membrane |
2 |
|
major depressive disorder |
2 |
|
mammals, rat |
2 |
|
matrix metalloproteinases - metabolism |
2 |
|
mediators, hif-1α |
2 |
|
mediators, vegf |
2 |
|
melatonin - administration & dosage - adverse effects - blood - pharmacokinetics |
2 |
|
melatonin - analogs & derivatives - antagonists & inhibitors - pharmacology - physiology |
2 |
|
melatonin - analogs & derivatives - pharmacology - physiology |
2 |
|
melatonin receptors |
2 |
|
methionine-choline deficient diet |
2 |
|
mice, inbred icr |
2 |
|
milk thistle-derived substances |
2 |
|
mitophagy |
2 |
|
mitosis - physiology |
2 |
|
mobile pervasive networks |
2 |
|
models, animal |
2 |
|
models, neurological |
2 |
|
motivational beliefs |
2 |
|
mucociliary clearance |
2 |
|
nasal mucosa - physiology - ultrastructure |
2 |
|
neuroinflammation |
2 |
|
nf-kappa b - analysis |
2 |
|
ng-nitroarginine methyl ester - pharmacology |
2 |
|
nitric oxide - analysis |
2 |
|
nitric oxide - metabolism - physiology |
2 |
|
nitric oxide - physiology |
2 |
|
nitric oxide synthase |
2 |
|
nitric oxide synthase - antagonists & inhibitors - metabolism |
2 |
|
nitric oxide synthase - genetics - metabolism |
2 |
|
nitric oxide synthase type ii |
2 |
|
nitric oxide synthase type ii - analysis - antagonists & inhibitors - genetics |
2 |
|
nitric oxide synthase type ii - genetics - metabolism |
2 |
|
nitric oxide synthase type ii - metabolism |
2 |
|
nitric oxide synthase type iii - analysis - genetics - metabolism |
2 |
|
nitric oxide synthases |
2 |
|
nlrp3 inflammasome |
2 |
|
non-alcoholic steatohepatitis |
2 |
|
nude mice |
2 |
|
on-site testing |
2 |
|
operational efficiencies |
2 |
|
oxygen - metabolism |
2 |
|
ph |
2 |
|
pharmacokinetics |
2 |
|
phenols - pharmacology |
2 |
|
phorbol 12,13-dibutyrate - pharmacology |
2 |
|
physiology education |
2 |
|
polymerase chain reaction |
2 |
|
problem-based learning |
2 |
|
procollagen - genetics |
2 |
|
professional self-efficacy |
2 |
|
propylene glycol |
2 |
|
prostaglandin |
2 |
|
protein kinase c - drug effects - metabolism |
2 |
|
proteomics |
2 |
|
pseudomonas aeruginosa - isolation & purification |
2 |
|
pseudomonas aeruginosa pyocyanin |
2 |
|
pseudomonas infections - complications - metabolism |
2 |
|
pyocyanine - pharmacology |
2 |
|
random allocation |
2 |
|
receptor, endothelin a |
2 |
|
receptor, melatonin, mt1 - antagonists & inhibitors - genetics - metabolism |
2 |
|
receptor, melatonin, mt2 - antagonists & inhibitors - genetics - metabolism |
2 |
|
receptors, cytokine - genetics - metabolism |
2 |
|
receptors, endothelin - genetics - metabolism |
2 |
|
receptors, erythropoietin - metabolism |
2 |
|
receptors, melatonin - antagonists & inhibitors - drug effects |
2 |
|
receptors, melatonin - antagonists & inhibitors - metabolism |
2 |
|
receptors, melatonin - drug effects - physiology |
2 |
|
receptors, vegf |
2 |
|
reference values |
2 |
|
respiration |
2 |
|
respiration - drug effects |
2 |
|
respiratory tract diseases - etiology - physiopathology |
2 |
|
respiratory tract infections - complications |
2 |
|
rfid |
2 |
|
rfid technology |
2 |
|
rna, messenger - drug effects - metabolism |
2 |
|
scd1 |
2 |
|
sex characteristics |
2 |
|
sleep apnea syndromes - metabolism - pathology - physiopathology |
2 |
|
smt |
2 |
|
sputum |
2 |
|
sputum - chemistry - cytology - microbiology |
2 |
|
superoxide dismutase |
2 |
|
tea - chemistry |
2 |
|
teaching |
2 |
|
tetrahydronaphthalenes - pharmacology |
2 |
|
tissue inhibitor of metalloproteinases - metabolism |
2 |
|
traditional internet |
2 |
|
transcription factor ap-1 - analysis |
2 |
|
transcription factors - metabolism - physiology |
2 |
|
transcription factors - physiology |
2 |
|
transforming growth factor beta1 - genetics |
2 |
|
transforming growth factor beta1 - metabolism |
2 |
|
tryptamines - pharmacology |
2 |
|
tumor necrosis factor |
2 |
|
tumor necrosis factor-alpha - analysis |
2 |
|
tumor necrosis factor-alpha - metabolism |
2 |
|
txnip |
2 |
|
type-i cell |
2 |
|
type-i cells |
2 |
|
tyrosine - analogs & derivatives - metabolism |
2 |
|
tyrosine 3-monooxygenase - genetics - metabolism |
2 |
|
undergraduate medical curricula |
2 |
|
up-regulation - drug effects |
2 |
|
up-regulation - physiology |
2 |
|
vascular endothelial growth factor a - genetics - metabolism |
2 |
|
vascular endothelial growth factor a - metabolism - physiology |
2 |
|
vegf |
2 |
|
virtual reality |
2 |
|
wireless pervasive |
2 |
|
wnt |
2 |
|
zeaxanthin dipalmitate |
2 |
|
acetamides - pharmacology |
1 |
|
acoustic radiation force impulse |
1 |
|
acute-on-chronic liver failure |
1 |
|
adenocarcinoma - blood supply - ultrastructure |
1 |
|
adenocarcinoma - chemistry - diagnosis |
1 |
|
adenocarcinoma - metabolism |
1 |
|
adenoid cystic carcinoma |
1 |
|
adenolymphoma - chemistry - diagnosis |
1 |
|
adenolymphoma - metabolism |
1 |
|
adenoma - blood supply - ultrastructure |
1 |
|
adenoma, pleomorphic - chemistry - diagnosis |
1 |
|
adenoma, pleomorphic - metabolism |
1 |
|
administration, oral |
1 |
|
airway biopsy |
1 |
|
airway inflammation |
1 |
|
alcohol |
1 |
|
alcohol drinking - adverse effects - pathology |
1 |
|
alcohol drinking - genetics - metabolism - pathology |
1 |
|
alcoholic liver injury |
1 |
|
analysis of variance |
1 |
|
anatomy education |
1 |
|
angiogenesis |
1 |
|
angiotensin-converting enzyme inhibitors - pharmacology |
1 |
|
aniline hydroxylase - metabolism |
1 |
|
animal model |
1 |
|
anterior cruciate ligament |
1 |
|
antigens, cd - analysis |
1 |
|
antigens, differentiation, myelomonocytic - analysis |
1 |
|
antihypertensive agents - pharmacology |
1 |
|
antineoplastic agents - pharmacology |
1 |
|
antioxidant responses |
1 |
|
apoptosis - drug effects |
1 |
|
arginine - therapeutic use |
1 |
|
asia - epidemiology |
1 |
|
aspartate aminotransferase to platelet ratio index |
1 |
|
assessment |
1 |
|
biological markers - analysis |
1 |
|
biopsy |
1 |
|
blood vessels |
1 |
|
blood vessels - pathology - ultrastructure |
1 |
|
blotting, western |
1 |
|
bmp |
1 |
|
bmps |
1 |
|
bone morphogenetic protein 2 |
1 |
|
bone morphogenetic protein 3 |
1 |
|
bone morphogenetic protein 4 |
1 |
|
bone morphogenetic protein 5 |
1 |
|
bone morphogenetic protein receptors, type i |
1 |
|
bone morphogenetic protein-2 |
1 |
|
bone morphogenetic proteins |
1 |
|
bone morphogenetic proteins (bmps) |
1 |
|
bone morphogenetic proteins - analysis |
1 |
|
bone morphogenetic proteins - analysis - genetics |
1 |
|
bone morphogenetic proteins - biosynthesis |
1 |
|
bone morphogenetic proteins - biosynthesis - genetics |
1 |
|
bone morphogenetic proteins - genetics |
1 |
|
bone morphogenetic proteins - genetics - metabolism |
1 |
|
bone morphogenetic proteins - metabolism |
1 |
|
breath tests |
1 |
|
bronchiectasis - diagnosis |
1 |
|
bronchiectasis - diagnosis - epidemiology - microbiology - physiopathology - therapy |
1 |
|
bronchiectasis - immunology - pathology |
1 |
|
bronchoscopy |
1 |
|
cancer |
1 |
|
carbon tetrachloride - adverse effects |
1 |
|
carcinoma (癌) |
1 |
|
carcinoma, adenoid cystic - chemistry - diagnosis |
1 |
|
carcinoma, adenoid cystic - metabolism |
1 |
|
carcinoma, adenoid cystic - metabolism - mortality |
1 |
|
carcinoma, mucoepidermoid - chemistry - diagnosis |
1 |
|
carcinoma, mucoepidermoid - metabolism |
1 |
|
carcinoma, squamous cell - metabolism |
1 |
|
cell count |
1 |
|
cell culture techniques |
1 |
|
cell differentiation - physiology |
1 |
|
cell division |
1 |
|
cell division - genetics |
1 |
|
cell membrane - chemistry |
1 |
|
cell nucleus - ultrastructure |
1 |
|
cell proliferation |
1 |
|
cell size - physiology |
1 |
|
cell transformation, neoplastic - pathology |
1 |
|
central nervous system depressants - administration & dosage - metabolism |
1 |
|
central nervous system depressants - blood - pharmacology |
1 |
|
central nervous system depressants - blood - toxicity |
1 |
|
cheek |
1 |
|
chemokine ccl2 - genetics |
1 |
|
chemokine cxcl2 |
1 |
|
chemokines - genetics - physiology |
1 |
|
chemoresistance |
1 |
|
chymotrypsin - metabolism |
1 |
|
ciliary assessment |
1 |
|
ciliary motility disorders - diagnosis - pathology |
1 |
|
ciliary neurotrophic factor - biosynthesis - genetics |
1 |
|
ckap4 |
1 |
|
cleft palate |
1 |
|
cleft palate - chemically induced - embryology - metabolism |
1 |
|
cleft palate - chemically induced - pathology |
1 |
|
cleft palate - embryology - genetics |
1 |
|
cntfr |
1 |
|
collagen - metabolism |
1 |
|
colon - cytology |
1 |
|
colonic neoplasms - enzymology - pathology |
1 |
|
colorectal neoplasms - blood supply - ultrastructure |
1 |
|
colorectal neoplasms - pathology |
1 |
|
colorectum |
1 |
|
coloring agents - diagnostic use |
1 |
|
condensation |
1 |
|
cross sectional |
1 |
|
crypts |
1 |
|
curcumin - pharmacology |
1 |
|
cyclin d1 - biosynthesis |
1 |
|
cyclooxygenase 1 |
1 |
|
cyclooxygenase 2 |
1 |
|
cyclooxygenase inhibitor |
1 |
|
cytochrome p-450 cyp2e1 - metabolism |
1 |
|
cytokines - biosynthesis - immunology |
1 |
|
cytoplasm - chemistry |
1 |
|
cytoplasm - ultrastructure |
1 |
|
developing countries |
1 |
|
development |
1 |
|
diagnosis |
1 |
|
diagnosis, differential |
1 |
|
diet |
1 |
|
dietary fats, unsaturated - administration & dosage |
1 |
|
differentiation |
1 |
|
dinoprost - analogs & derivatives - blood |
1 |
|
dna, complementary - biosynthesis |
1 |
|
drug combinations |
1 |
|
drug interactions |
1 |
|
drug-induced liver injury - diet therapy - pathology |
1 |
|
drug-induced liver injury - etiology - immunology |
1 |
|
elastase |
1 |
|
electron microscopy |
1 |
|
electrophoretic mobility shift assay |
1 |
|
embryo, mammalian |
1 |
|
endothelium-dependent relaxations |
1 |
|
endotoxemia - immunology |
1 |
|
endotoxemia - physiopathology |
1 |
|
endotoxins |
1 |
|
endotoxins - blood |
1 |
|
endotoxins - metabolism |
1 |
|
endotoxins - physiology |
1 |
|
epithelium |
1 |
|
epithelium - blood supply - pathology |
1 |
|
epithelium - chemistry |
1 |
|
ethanol - administration & dosage |
1 |
|
ethanol - administration & dosage - metabolism |
1 |
|
ethanol - administration & dosage - pharmacology |
1 |
|
ethanol - administration & dosage - toxicity |
1 |
|
ethanol - blood - pharmacology |
1 |
|
ethanol - blood - toxicity |
1 |
|
ethanol - toxicity |
1 |
|
expression |
1 |
|
extra virgin olive oil |
1 |
|
facial neoplasms - metabolism - pathology |
1 |
|
facial nerve |
1 |
|
facial nerve (面神经) |
1 |
|
facial nerve - metabolism - physiopathology |
1 |
|
facial nerve injuries - physiopathology |
1 |
|
fatty acids - administration & dosage |
1 |
|
fatty acids - pharmacology |
1 |
|
fatty acids, unsaturated - administration & dosage |
1 |
|
fatty liver |
1 |
|
fatty liver, alcoholic - pathology |
1 |
|
fibroblast growth factor 2 - biosynthesis - genetics |
1 |
|
fibroblast growth factor 7 |
1 |
|
fibroblast growth factors - biosynthesis - genetics |
1 |
|
fish oils - administration & dosage |
1 |
|
follow-up studies |
1 |
|
forns index |
1 |
|
fosinopril - pharmacology |
1 |
|
fracture healing |
1 |
|
garlic |
1 |
|
gene expression regulation, developmental - drug effects |
1 |
|
glucose tolerance |
1 |
|
growth substances - genetics |
1 |
|
gsk3β |
1 |
|
gskip |
1 |
|
haemophilus influenzae - pathogenicity |
1 |
|
hepatic lipogenesis |
1 |
|
hepatitis b virus |
1 |
|
hepatitis, alcoholic - genetics - immunology - pathology |
1 |
|
hepatocellular carcinoma |
1 |
|
hepatocytes - immunology |
1 |
|
hepatotoxicity |
1 |
|
histopathology |
1 |
|
honey |
1 |
|
i-kappa b proteins - metabolism |
1 |
|
image cytometry - methods |
1 |
|
image processing, computer-assisted |
1 |
|
immunoenzyme techniques |
1 |
|
in situ hybridization (原位雜交) |
1 |
|
in-situ hybridization |
1 |
|
inducible nitric oxide synthase |
1 |
|
infection |
1 |
|
inflammasome, metabolic disorders, review |
1 |
|
inflammation - chemically induced - prevention & control |
1 |
|
inflammation mediators - physiology |
1 |
|
interferon-gamma - biosynthesis - genetics |
1 |
|
intestinal mucosa - blood supply - ultrastructure |
1 |
|
intestinal mucosa - cytology |
1 |
|
intestinal mucosa - pathology |
1 |
|
iron - metabolism |
1 |
|
isoenzymes - biosynthesis |
1 |
|
isoenzymes - genetics |
1 |
|
isoenzymes - metabolism |
1 |
|
jaw neoplasms - metabolism - pathology |
1 |
|
keratinocytes - metabolism |
1 |
|
kgf (kgf) |
1 |
|
ki-67 antigen |
1 |
|
ki-67 antigen - analysis |
1 |
|
kupffer cells - drug effects - physiology |
1 |
|
laryngeal mucosa (喉粘膜) |
1 |
|
leukoplakia, oral - genetics |
1 |
|
lipopolysaccharide |
1 |
|
liver - chemistry - metabolism - pathology |
1 |
|
liver - enzymology - pathology |
1 |
|
liver - immunology - pathology |
1 |
|
liver - pathology |
1 |
|
liver cirrhosis - chemically induced - pathology - prevention & control |
1 |
|
liver cirrhosis, alcoholic - diet therapy - pathology |
1 |
|
liver cirrhosis, alcoholic - prevention & control |
1 |
|
liver disease |
1 |
|
liver diseases, alcoholic - etiology - pathology |
1 |
|
liver diseases, alcoholic - genetics - metabolism - pathology |
1 |
|
liver diseases, alcoholic - metabolism - pathology - prevention & control |
1 |
|
liver diseases, alcoholic - pathology - physiopathology |
1 |
|
liver regeneration - immunology |
1 |
|
long non-coding rna |
1 |
|
lung - immunology - pathology |
1 |
|
lymphatic metastasis |
1 |
|
macrophage migration-inhibitory factors - biosynthesis - genetics - immunology |
1 |
|
macrophages |
1 |
|
macrophages - metabolism - pathology |
1 |
|
magnetic resonance imaging |
1 |
|
malignant |
1 |
|
mandibular fractures - genetics - metabolism - pathology |
1 |
|
matrix metalloproteinase |
1 |
|
matrix metalloproteinases |
1 |
|
measurement |
1 |
|
median nerve |
1 |
|
membrane glycoproteins - immunology |
1 |
|
membrane proteins |
1 |
|
mesenchymal stromal cells |
1 |
|
mesenchyme |
1 |
|
mesoderm - drug effects - metabolism - pathology |
1 |
|
mesoderm - pathology |
1 |
|
metastasis |
1 |
|
mice, inbred balb c |
1 |
|
mice, mutant strains |
1 |
|
microscopy |
1 |
|
morphometry |
1 |
|
motoneuron |
1 |
|
motor neurons - metabolism |
1 |
|
mouth mucosa - blood supply |
1 |
|
mouth mucosa - blood supply - cytology - pathology |
1 |
|
mouth mucosa - chemistry |
1 |
|
mouth mucosa - metabolism |
1 |
|
mouth neoplasms - blood supply |
1 |
|
mouth neoplasms - metabolism |
1 |
|
mouth neoplasms - pathology |
1 |
|
movement |
1 |
|
mri |
1 |
|
myocardial infarction - pathology |
1 |
|
myocardium - pathology |
1 |
|
nash |
1 |
|
necrosis - chemically induced - etiology - pathology |
1 |
|
neoplasia |
1 |
|
neoplasm proteins - analysis |
1 |
|
neoplasms, multiple primary - chemistry - diagnosis |
1 |
|
neovascularization, pathologic - pathology |
1 |
|
nerve regeneration |
1 |
|
nerve sheath neoplasms - metabolism - pathology |
1 |
|
nerve sheath tumor |
1 |
|
nervous system neoplasms - metabolism |
1 |
|
neurilemmoma - metabolism |
1 |
|
neurilemmoma - metabolism - pathology |
1 |
|
neutrophils - metabolism - pathology |
1 |
|
nf-kappa b - antagonists & inhibitors - biosynthesis - genetics |
1 |
|
nitric oxide - blood |
1 |
|
nitric oxide synthase - drug effects - metabolism |
1 |
|
nitric oxide synthase - metabolism |
1 |
|
non-alcoholic fatty liver |
1 |
|
non-invasive diagnosis |
1 |
|
nonheme iron proteins - metabolism |
1 |
|
nrf2/dkk1 |
1 |
|
oral |
1 |
|
oral cancer |
1 |
|
oral cheek epithelium |
1 |
|
p53 |
1 |
|
palate |
1 |
|
palate - abnormalities |
1 |
|
palate - drug effects - embryology |
1 |
|
palate - embryology |
1 |
|
palmitate |
1 |
|
papilloma - genetics |
1 |
|
parotid diseases - metabolism - pathology |
1 |
|
parotid gland - chemistry - pathology |
1 |
|
parotid gland - metabolism |
1 |
|
parotid neoplasms |
1 |
|
parotid neoplasms - chemistry - diagnosis |
1 |
|
parotid neoplasms - metabolism - pathology |
1 |
|
pcna |
1 |
|
peripheral nervous system diseases - metabolism |
1 |
|
pneumonia, bacterial - diagnosis |
1 |
|
precancer |
1 |
|
precancerous conditions - blood supply |
1 |
|
precancerous conditions - metabolism |
1 |
|
precancerous conditions - pathology |
1 |
|
precancers |
1 |
|
predictive value of tests |
1 |
|
pregnancy |
1 |
|
prognosis |
1 |
|
proliferating cell nuclear antigen |
1 |
|
proliferating cell nuclear antigen - analysis |
1 |
|
proliferating cell nuclear antigen - metabolism |
1 |
|
proliferation |
1 |
|
prostaglandin-endoperoxide synthases - biosynthesis |
1 |
|
prostaglandin-endoperoxide synthases - genetics |
1 |
|
prostaglandin-endoperoxide synthases - metabolism |
1 |
|
protein-serine-threonine kinases - analysis |
1 |
|
pseudomonas aeruginosa - pathogenicity |
1 |
|
pseudomonas infections - diagnosis |
1 |
|
public engagement |
1 |
|
rats, wistar |
1 |
|
receptor |
1 |
|
receptors, cell surface - immunology |
1 |
|
receptors, growth factor - analysis |
1 |
|
recombinant proteins |
1 |
|
rectum - cytology |
1 |
|
regeneration (再生) |
1 |
|
respiratory system - pathology |
1 |
|
retinoic acid |
1 |
|
retrospective studies |
1 |
|
rhbmp-2 |
1 |
|
rna, messenger - analysis - genetics |
1 |
|
rna, messenger - biosynthesis |
1 |
|
rna, messenger - metabolism |
1 |
|
rodents |
1 |
|
saccharin - diagnostic use |
1 |
|
salivary gland |
1 |
|
salivary gland neoplasm |
1 |
|
salivary gland neoplasms - metabolism - mortality |
1 |
|
schwann cell |
1 |
|
self administration |
1 |
|
sialadenitis - diagnosis - metabolism |
1 |
|
sialadenitis - metabolism |
1 |
|
skeletal muscle |
1 |
|
solvents - adverse effects |
1 |
|
specimen handling |
1 |
|
sputum - chemistry |
1 |
|
staining and labeling |
1 |
|
stem cells - pathology |
1 |
|
superoxide |
1 |
|
survival analysis |
1 |
|
survival rate |
1 |
|
telomerase - metabolism |
1 |
|
teratogens - pharmacology |
1 |
|
tetrazoles - pharmacology |
1 |
|
tgf-β |
1 |
|
tgf-β1 |
1 |
|
thiobarbituric acid reactive substances - metabolism |
1 |
|
tissue distribution - drug effects |
1 |
|
toll-like receptors |
1 |
|
transcription, genetic |
1 |
|
transforming growth factor beta |
1 |
|
transforming growth factor beta - analysis - genetics |
1 |
|
transforming growth factor beta - genetics |
1 |
|
tretinoin - adverse effects |
1 |
|
tretinoin - pharmacology |
1 |
|
trigeminal nerve |
1 |
|
trigeminal nerve - metabolism |
1 |
|
tumor markers, biological - metabolism |
1 |
|
tumor necrosis factor-alpha - biosynthesis |
1 |
|
tumor necrosis factor-alpha - genetics |
1 |
|
tumor suppressor protein p53 - metabolism |
1 |
|
tumorigenesis |
1 |
|
ultrasound |
1 |
|
valine - analogs & derivatives - pharmacology |
1 |
|
ventricular remodeling - drug effects |
1 |
|
virulence factors |
1 |
|
weight gain |
1 |
|
xenobiotic responses |
1 |
|
young adult |
1 |
